Stem cell therapy
Neurodegenerative diseases
PreclinicalActive
Key Facts
About Regencell Bioscience
Regencell Bioscience combines traditional Chinese medicine with modern biotechnology to develop innovative treatments for autism spectrum disorder, attention deficit hyperactivity disorder (ADHD), and other neurodegenerative conditions. The company operates through its proprietary TCM-based formulations and stem cell therapy platforms, targeting underserved patient populations with limited treatment options. Based in Hong Kong, Regencell aims to bridge Eastern traditional medicine with Western regulatory standards to bring novel therapeutics to global markets.
View full company profileOther Neurodegenerative diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| ANAVEX®1-41 | Anavex Life Sciences | Preclinical |